GlassScriptPhysician profile
Francis Dang
NPI 1194365148
$3,598.14
in general payments reported to CMS, 2019-2025
14 companies · $641 in 2025
The $641 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $634 · 2022: $1,088 · 2023: $630 · 2024: $606 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,777 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,776.67 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $948.93 | 2021-2024 | |
| Genzyme Corporation | $639.54 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $372.63 | 2021-2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $356.28 | 2021-2025 | |
| Janssen Biotech, INC. | $337.74 | 2021-2025 | Tremfya |
| Lilly USA, LLC | $251.52 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Incyte Corporation | $165.72 | 2022-2023 | Opzelura |
| Ucb, INC. | $129.58 | 2021-2025 | Bimzelx |
| Paratek Pharmaceuticals, INC. | $115.22 | 2021 | |
| Pfizer INC. | $98.34 | 2023-2024 | |
| Arcutis Biotherapeutics, INC. | $64.45 | 2023-2024 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $63.91 | 2023-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $38.06 | 2025 | |
| Boston Scientific Corporation | $16.22 | 2024 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Dang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.